Literature DB >> 17196063

Measurement-based psychiatry: definitions of response, remission, stability, and relapse in schizophrenia.

Stefan Leucht1, John M Kane.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17196063     DOI： 10.4088/jcp.v67n1120

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  12 in total

Review 1.  Methodological issues in current antipsychotic drug trials.

Authors:  Stefan Leucht; Stephan Heres; Johannes Hamann; John M Kane
Journal:  Schizophr Bull       Date:  2008-01-29       Impact factor: 9.306

2.  Cognitive deficits in schizophrenia: short-term and long-term.

Authors:  John M Kane; Todd Lencz
Journal:  World Psychiatry       Date:  2008-02       Impact factor: 49.548

3.  Challenging the understanding of significant improvement and outcome in schizophrenia - the concept of reliable and clinically significant change methods.

Authors:  Rebecca Schennach; Hans-Jürgen Möller; Michael Obermeier; Florian Seemüller; Markus Jäger; Max Schmauss; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; Isabella Heuser; Wolfgang Maier; Matthias R Lemke; Eckart Rüther; Stefan Klingberg; Markus Gastpar; Richard Musil; Ilja Spellmann; Michael Riedel
Journal:  Int J Methods Psychiatr Res       Date:  2015-07-14       Impact factor: 4.035

4.  Paliperidone Palmitate Treatment in Outpatient Care Setting: A Naturalistic Study.

Authors:  Rosaria Di Lorenzo; Michela Cameli; Marisa Bolondi; Giulia Landi; Valentina Moretti; Chiara Piemonte; Gabriella Pollutri
Journal:  Psychopharmacol Bull       Date:  2016-03-01

5.  How Many Patients With Schizophrenia Do Not Respond to Antipsychotic Drugs in the Short Term? An Analysis Based on Individual Patient Data From Randomized Controlled Trials.

Authors:  Myrto T Samara; Adriani Nikolakopoulou; Georgia Salanti; Stefan Leucht
Journal:  Schizophr Bull       Date:  2019-04-25       Impact factor: 9.306

Review 6.  Quantifying clinical relevance in the treatment of schizophrenia.

Authors:  Christoph U Correll; Taishiro Kishimoto; Jimmi Nielsen; John M Kane
Journal:  Clin Ther       Date:  2011-12       Impact factor: 3.393

7.  Antipsychotic agents: efficacy and safety in schizophrenia.

Authors:  Arão Nogueira de Araújo; Eduardo Pondé de Sena; Irismar Reis de Oliveira; Mario F Juruena
Journal:  Drug Healthc Patient Saf       Date:  2012-11-29

8.  Treatment Response in First-episode Schizophrenia.

Authors:  Rebecca Schennach; Michael Riedel; Richard Musil; Hans-Jürgen Möller
Journal:  Clin Psychopharmacol Neurosci       Date:  2012-08-31       Impact factor: 2.582

9.  Response after Infection-Associated Rise in Clozapine Levels in Treatment-Resistant Schizoaffective Disorder.

Authors:  Nina H Grootendorst-van Mil; Anna R M Huiskens; Sieds Dieleman; Tom K Birkenhäger
Journal:  Case Rep Psychiatry       Date:  2018-02-12

10.  Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study.

Authors:  Emanuela Martinuzzi; Susana Barbosa; Douglas Daoudlarian; Wafa Bel Haj Ali; Cyprien Gilet; Lionel Fillatre; Olfa Khalfallah; Réjane Troudet; Stéphane Jamain; Guillaume Fond; Iris Sommer; Stefan Leucht; Paola Dazzan; Philip McGuire; Celso Arango; Covadonga M Diaz-Caneja; Wolfgang Fleischhacker; Dan Rujescu; Birte Glenthøj; Inge Winter; René Sylvain Kahn; Robert Yolken; Shon Lewis; Richard Drake; Laetitia Davidovic; Marion Leboyer; Nicolas Glaichenhaus
Journal:  Transl Psychiatry       Date:  2019-01-17       Impact factor: 7.989
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.